{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:19:36Z","timestamp":1721128776602},"reference-count":19,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Measles is a highly contagious respiratory virus infection, with typical clinical symptoms including maculopapular rash, fever, cough, coryza, and conjunctivitis. Despite implementation of widespread vaccination programs throughout the world, the rates of global morbidity and mortality are still considerable. This study was performed to design a reliable indirect enzyme-linked immunosorbent assay (ELISA) to measure measles-specific immunoglobulin M (IgM). First, human IgM was purified, and then an anti-IgM antibody was produced in rabbits and purified in a multistep process. The rabbit IgG against human IgM was conjugated with peroxidase. Measles virus-infected Vero cells produced viral antigen. One hundred serum samples from infants of 9 to 18 months of age, mostly vaccinated, were evaluated for determining the presence of specific IgM antibodies against measles virus. The samples were also evaluated for neutralizing antibodies against measles virus by a microneutralization test (MNT). By comparing the results of the ELISA with those of MNT, it was demonstrated that ELISA had a sensitivity and specificity of 100 and 92%, respectively. On the other hand, when the results obtained by our ELISA system were compared with those of an imported measles virus IgM ELISA kit (EIAgen; Adaltis Italia SPa, Bologna, Italy), a high level of agreement was shown (\n            <jats:italic>k<\/jats:italic>\n            = 0.926).\n          <\/jats:p>","DOI":"10.1128\/cdli.10.3.439-442.2003","type":"journal-article","created":{"date-parts":[[2003,5,8]],"date-time":"2003-05-08T19:08:45Z","timestamp":1052420925000},"page":"439-442","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Development of an Enzyme-Linked Immunosorbent Assay for Immunoglobulin M Antibodies against Measles Virus"],"prefix":"10.1128","volume":"10","author":[{"given":"F.","family":"Roodbari","sequence":"first","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Roustai","sequence":"additional","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mostafaie","sequence":"additional","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Soleimanjdahi","sequence":"additional","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Sarrami","family":"Foroshani","sequence":"additional","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sabahi","sequence":"additional","affiliation":[{"name":"Departments of Virology"},{"name":"Immunology, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ije\/21.5.1007","volume":"21","year":"1992","unstructured":"Agoes, M. M., L. E. Markowitz, I. Straub, and I. Domok. 1992. The 1988-1989 measles epidemics in Hungary: assessment of vaccine failure. Int. J. Epidemiol.21:1007-1013.","journal-title":"Int. J. Epidemiol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Bradford M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. 72 : 248-254.","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_3_2_4_2","first-page":"1","volume":"46","year":"1997","unstructured":"Centers for Disease Control and Prevention. 1997. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan-American Health Organization, and CDC. Morb. Mortal. Wkly. Rep.46:1-20.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_5_2","first-page":"249","volume":"6","year":"1993","unstructured":"Daie Parizi, M. H., M. Janghorni, and K. Ghorbani. 1993. Measles epidemics in Kerman, Iran. Med. J. I. R Iran6:249-256.","journal-title":"Med. J. I. R Iran"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.3.987-991.2000"},{"key":"e_1_3_2_7_2","unstructured":"Gorvey J. S. et al. 1977. Methods in immunology. W. A. Benjamin Inc. New York N.Y."},{"key":"e_1_3_2_8_2","first-page":"207","volume":"72","year":"1994","unstructured":"Grandien, M. A., et al. 1994. Laboratory diagnosis of measles infection and monitoring of measles immunization: memorandum from a W. H. O. meeting. Bull. W. H. O.72:207-211.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_9_2","unstructured":"Griffin D. E. and W. J. Bellini. 1996. Measles virus p. 1267-1313. In B. N. Fields D. M. Knipe and P. M. Howley (ed.) Fields virology 3rd ed. Lippincott-Raven Publishers Philadelphia Pa."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/infdis\/170.Supplement_1.S24","volume":"170","year":"1994","unstructured":"Griffin, D. E., B. J. Ward, and L. M. Esolen. 1994. Pathogenesis of measles virus infection: a hypothesis for altered immune responses. J. Infect. Dis.170:S24-S37.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_3_2_12_2","unstructured":"Lennette E. H. 1995. Diagnosis procedure for viral rickettsial and chlamydial infections 7th ed. American Public Health Association Washington D.C."},{"key":"e_1_3_2_13_2","first-page":"S555","volume":"13","year":"1997","unstructured":"Markowitz, L. E., et al. 1997. The burden of acute respiratory infections due to measles in developing countries and the potential impact of measles vaccine. Rev. Infect. Dis.13(Suppl. 6):S555-S561.","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.12.2865-2867.1991"},{"key":"e_1_3_2_15_2","unstructured":"National Institute for Prevention and Control of Diseases. 1998. Reports of epidemiological studies in Iran years 1996 1997 and 1998. Ministry of Health and Health Education Tehran Iran."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.2.296-298.1985"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.99-104.2000"},{"key":"e_1_3_2_18_2","unstructured":"Redd S. C. L. E. Markowitz and S. L. Katz. 1999. Measles vaccine p. 222-268. In S. A. Plotkin and W. A. Orenstein (ed.) Vaccines 3rd ed. W. B. Saunders Co. New York N.Y."},{"key":"e_1_3_2_19_2","unstructured":"Spector S. and G. Lancz. 1994. Clinical virology manual 2nd ed. Elsevier New York N.Y."},{"key":"e_1_3_2_20_2","unstructured":"Wilson M. B. and P. K. Nakane. 1978. Immunofluorescence and related staining techniques. Elsevier\/North Holland Biomedical Press Amsterdam The Netherlands."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.3.439-442.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CDLI.10.3.439-442.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:33:12Z","timestamp":1627590792000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CDLI.10.3.439-442.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1128\/CDLI.10.3.439-442.2003"],"URL":"https:\/\/doi.org\/10.1128\/cdli.10.3.439-442.2003","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2002-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-01-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}